Clinical Trial Update: Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating that adjuvant PRGN-2012 for adults with recurrent respiratory papillomatosis is in Phase 1/2 and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Respiratory Papillomatosis

Drugs mentioned

• PRGN-2012

Snippet

Sponsor: Precigen, Inc | Conditions: Recurrent Respiratory Papillomatosis, Papillomavirus Infections | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING